tiprankstipranks
Austar Lifesciences Ltd. (HK:6118)
:6118
Hong Kong Market
6118
Austar Lifesciences Ltd.
RESEARCH TOOLSreports

Austar Lifesciences Ltd. (6118) Ratios

0 Followers

Austar Lifesciences Ltd. Ratios

HK:6118's free cash flow for Q2 2025 was ¥0.21. For the 2025 fiscal year, HK:6118's free cash flow was decreased by ¥ and operating cash flow was ¥0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 1.36 1.31 1.34 1.32 1.46
Quick Ratio
 1.12 1.10 1.13 1.04 1.09
Cash Ratio
 0.23 0.14 0.14 0.10 0.17
Solvency Ratio
 0.06 0.04 -0.05 0.08 0.23
Operating Cash Flow Ratio
 0.10 0.08 -0.05 -0.03 -0.09
Short-Term Operating Cash Flow Coverage
 0.44 0.30 -0.20 -0.17 -1.84
Net Current Asset Value
¥ 309.92M¥ 261.59M¥ 190.32M¥ 295.82M¥ 406.88M
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.19 0.23 0.14 0.08
Debt-to-Equity Ratio
 0.42 0.51 0.64 0.38 0.20
Debt-to-Capital Ratio
 0.29 0.34 0.39 0.27 0.16
Long-Term Debt-to-Capital Ratio
 0.07 0.03 0.13 0.04 0.06
Financial Leverage Ratio
 2.59 2.63 2.79 2.66 2.60
Debt Service Coverage Ratio
 0.21 0.18 0.07 0.62 1.39
Interest Coverage Ratio
 4.39 2.05 -2.15 12.13 70.86
Debt to Market Cap
 0.93 1.29 0.59 0.28 0.02
Interest Debt Per Share
 0.69 0.82 0.99 0.68 0.31
Net Debt to EBITDA
 0.91 3.33 13.22 1.27 -0.33
Profitability Margins
Gross Profit Margin
19.17%20.08%19.05%22.66%23.77%
EBIT Margin
2.34%2.32%-1.16%5.69%5.80%
EBITDA Margin
4.85%4.71%1.43%7.41%6.48%
Operating Profit Margin
3.27%2.34%-1.70%5.40%15.48%
Pretax Profit Margin
3.15%1.41%-1.95%5.54%15.84%
Net Profit Margin
2.22%1.07%-6.43%4.05%13.76%
Continuous Operations Profit Margin
2.16%0.90%-1.97%4.67%13.53%
Net Income Per EBT
70.37%75.94%329.77%73.17%86.87%
EBT Per EBIT
96.58%60.18%114.72%102.72%102.34%
Return on Assets (ROA)
1.58%0.77%-5.26%3.66%13.56%
Return on Equity (ROE)
4.12%2.03%-14.68%9.75%35.25%
Return on Capital Employed (ROCE)
5.27%3.93%-3.06%11.31%34.33%
Return on Invested Capital (ROIC)
2.80%1.82%-2.28%7.84%27.58%
Return on Tangible Assets
1.61%0.79%-5.36%3.75%13.70%
Earnings Yield
9.41%5.86%-15.60%9.57%4.41%
Efficiency Ratios
Receivables Turnover
 1.55 1.48 1.77 2.16 2.99
Payables Turnover
 2.66 3.14 3.52 4.14 4.36
Inventory Turnover
 4.38 5.03 5.87 4.55 3.63
Fixed Asset Turnover
 3.86 3.62 4.62 4.97 6.46
Asset Turnover
 0.71 0.72 0.82 0.90 0.99
Working Capital Turnover Ratio
 3.66 3.95 4.21 4.46 4.97
Cash Conversion Cycle
 182.14 202.97 164.24 161.42 138.73
Days of Sales Outstanding
 235.98 246.70 205.85 169.30 121.88
Days of Inventory Outstanding
 83.33 72.57 62.17 80.22 100.58
Days of Payables Outstanding
 137.17 116.30 103.78 88.09 83.73
Operating Cycle
 319.31 319.27 268.01 249.51 222.45
Cash Flow Ratios
Operating Cash Flow Per Share
 0.23 0.19 -0.12 -0.07 -0.20
Free Cash Flow Per Share
 0.22 0.15 -0.26 -0.30 -0.40
CapEx Per Share
 0.01 0.04 0.14 0.23 0.20
Free Cash Flow to Operating Cash Flow
 0.95 0.79 2.13 4.09 1.97
Dividend Paid and CapEx Coverage Ratio
 20.73 4.82 -0.88 -0.32 -1.03
Capital Expenditure Coverage Ratio
 20.73 4.82 -0.88 -0.32 -1.03
Operating Cash Flow Coverage Ratio
 0.34 0.25 -0.13 -0.11 -0.67
Operating Cash Flow to Sales Ratio
 0.08 0.07 -0.04 -0.02 -0.05
Free Cash Flow Yield
31.48%28.54%-18.37%-16.98%-3.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.62 17.07 -6.41 10.45 22.70
Price-to-Sales (P/S) Ratio
 0.24 0.18 0.41 0.42 3.12
Price-to-Book (P/B) Ratio
 0.43 0.35 0.94 1.02 8.00
Price-to-Free Cash Flow (P/FCF) Ratio
 3.18 3.50 -5.44 -5.89 -30.85
Price-to-Operating Cash Flow Ratio
 3.02 2.78 -11.61 -24.11 -60.85
Price-to-Earnings Growth (PEG) Ratio
 -2.43 -0.15 0.03 -0.15 0.03
Price-to-Fair Value
 0.43 0.35 0.94 1.02 8.00
Enterprise Value Multiple
 5.77 7.21 42.13 6.99 47.86
Enterprise Value
 424.65M 509.56M 1.06B 1.12B 6.25B
EV to EBITDA
 5.77 7.21 42.13 6.99 47.86
EV to Sales
 0.28 0.34 0.60 0.52 3.10
EV to Free Cash Flow
 3.77 6.51 -7.93 -7.20 -30.64
EV to Operating Cash Flow
 3.59 5.16 -16.91 -29.46 -60.43
Tangible Book Value Per Share
 1.61 1.47 1.42 1.61 1.50
Shareholders’ Equity Per Share
 1.60 1.54 1.50 1.75 1.53
Tax and Other Ratios
Effective Tax Rate
 0.32 0.36 -0.01 0.16 0.15
Revenue Per Share
 2.96 2.93 3.43 4.21 3.93
Net Income Per Share
 0.07 0.03 -0.22 0.17 0.54
Tax Burden
 0.70 0.76 3.30 0.73 0.87
Interest Burden
 1.35 0.61 1.68 0.97 2.73
Research & Development to Revenue
 0.03 0.04 0.03 0.03 0.03
SG&A to Revenue
 0.14 0.16 0.08 0.06 0.06
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 3.36 6.14 1.82 -0.43 -0.37
Currency in CNY